United States Active Pharmaceutical Ingredients Market Report 2017

February 2017 | 115 pages | ID: UA9D3C500CCEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Active Pharmaceutical Ingredients

Revenue, means the sales value of Active Pharmaceutical Ingredients

This report studies sales (consumption) of Active Pharmaceutical Ingredients in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer
• Novartis International
• Sanofi
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Teva Pharmaceutical
• Eli Lilly and Company
• GlaxoSmithKline
• Merck & Co
• AbbVie
• Johnson & Johnson
• Bayer
• Sun Pharmaceutical Industries
• DSM
• Hisun Pharmacy
• Huahai Pharmaceutical
• North China Pharmaceutical Group
• Shandong Lukang Pharmaceutical
• Haerbin Pharmaceutical Group
• Shandong Xinhua Pharmaceutical
• Jiangsu Hengrui Medicine
• Lonza Group
• Aurobindo Pharma
• Lupin
• Biocon

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Synthetic APIs
• Biotech APIs

Split by applications, this report focuses on sales, market share and growth rate of Active Pharmaceutical Ingredients in each application, can be divided into

• Oncology
• Diabetes
• Cardiovascular Disease
• CNS and Neurological Disorders
• Endocrinology
• Other

Contents

United States Active Pharmaceutical Ingredients Market Report 2017

1 ACTIVE PHARMACEUTICAL INGREDIENTS OVERVIEW

1.1 Product Overview and Scope of Active Pharmaceutical Ingredients
1.2 Classification of Active Pharmaceutical Ingredients
  1.2.1 Synthetic APIs
  1.2.2 Biotech APIs
1.3 Application of Active Pharmaceutical Ingredients
  1.3.1 Oncology
  1.3.2 Diabetes
  1.3.3 Cardiovascular Disease
  1.3.4 CNS and Neurological Disorders
  1.3.5 Endocrinology
  1.3.6 Other
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Active Pharmaceutical Ingredients (2012-2022)
  1.4.1 United States Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2022)
  1.4.2 United States Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2022)

2 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS COMPETITION BY MANUFACTURERS

2.1 United States Active Pharmaceutical Ingredients Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Active Pharmaceutical Ingredients Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Active Pharmaceutical Ingredients Average Price by Manufactures (2015 and 2016)
2.4 Active Pharmaceutical Ingredients Market Competitive Situation and Trends
  2.4.1 Active Pharmaceutical Ingredients Market Concentration Rate
  2.4.2 Active Pharmaceutical Ingredients Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Active Pharmaceutical Ingredients Sales and Market Share by States (2012-2017)
3.2 United States Active Pharmaceutical Ingredients Revenue and Market Share by States (2012-2017)
3.3 United States Active Pharmaceutical Ingredients Price by States (2012-2017)

4 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Active Pharmaceutical Ingredients Sales and Market Share by Type (2012-2017)
4.2 United States Active Pharmaceutical Ingredients Revenue and Market Share by Type (2012-2017)
4.3 United States Active Pharmaceutical Ingredients Price by Type (2012-2017)
4.4 United States Active Pharmaceutical Ingredients Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Active Pharmaceutical Ingredients Sales and Market Share by Application (2012-2017)
5.2 United States Active Pharmaceutical Ingredients Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURERS PROFILES/ANALYSIS

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.1.2.1 Synthetic APIs
    6.1.2.2 Biotech APIs
  6.1.3 Pfizer Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis International
  6.2.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.2.2.1 Synthetic APIs
    6.2.2.2 Biotech APIs
  6.2.3 Novartis International Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sanofi
  6.3.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.3.2.1 Synthetic APIs
    6.3.2.2 Biotech APIs
  6.3.3 Sanofi Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Boehringer Ingelheim
  6.4.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.4.2.1 Synthetic APIs
    6.4.2.2 Biotech APIs
  6.4.3 Boehringer Ingelheim Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb
  6.5.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.5.2.1 Synthetic APIs
    6.5.2.2 Biotech APIs
  6.5.3 Bristol-Myers Squibb Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Teva Pharmaceutical
  6.6.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.6.2.1 Synthetic APIs
    6.6.2.2 Biotech APIs
  6.6.3 Teva Pharmaceutical Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Eli Lilly and Company
  6.7.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.7.2.1 Synthetic APIs
    6.7.2.2 Biotech APIs
  6.7.3 Eli Lilly and Company Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline
  6.8.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.8.2.1 Synthetic APIs
    6.8.2.2 Biotech APIs
  6.8.3 GlaxoSmithKline Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Merck & Co
  6.9.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.9.2.1 Synthetic APIs
    6.9.2.2 Biotech APIs
  6.9.3 Merck & Co Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 AbbVie
  6.10.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.10.2.1 Synthetic APIs
    6.10.2.2 Biotech APIs
  6.10.3 AbbVie Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Johnson & Johnson
6.12 Bayer
6.13 Sun Pharmaceutical Industries
6.14 DSM
6.15 Hisun Pharmacy
6.16 Huahai Pharmaceutical
6.17 North China Pharmaceutical Group
6.18 Shandong Lukang Pharmaceutical
6.19 Haerbin Pharmaceutical Group
6.20 Shandong Xinhua Pharmaceutical
6.21 Jiangsu Hengrui Medicine
6.22 Lonza Group
6.23 Aurobindo Pharma
6.24 Lupin
6.25 Biocon

7 ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING COST ANALYSIS

7.1 Active Pharmaceutical Ingredients Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Active Pharmaceutical Ingredients Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Active Pharmaceutical Ingredients Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FORECAST (2017-2022)

11.1 United States Active Pharmaceutical Ingredients Sales, Revenue Forecast (2017-2022)
11.2 United States Active Pharmaceutical Ingredients Sales Forecast by Type (2017-2022)
11.3 United States Active Pharmaceutical Ingredients Sales Forecast by Application (2017-2022)
11.4 Active Pharmaceutical Ingredients Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Active Pharmaceutical Ingredients
Table Classification of Active Pharmaceutical Ingredients
Figure United States Sales Market Share of Active Pharmaceutical Ingredients by Type in 2015
Figure Synthetic APIs Picture
Figure Biotech APIs Picture
Table Application of Active Pharmaceutical Ingredients
Figure United States Sales Market Share of Active Pharmaceutical Ingredients by Application in 2015
Figure Oncology Examples
Figure Diabetes Examples
Figure Cardiovascular Disease Examples
Figure CNS and Neurological Disorders Examples
Figure Endocrinology Examples
Figure Other Examples
Figure United States Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2022)
Figure United States Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2022)
Table United States Active Pharmaceutical Ingredients Sales of Key Manufacturers (2015 and 2016)
Table United States Active Pharmaceutical Ingredients Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Active Pharmaceutical Ingredients Sales Share by Manufacturers
Figure 2016 Active Pharmaceutical Ingredients Sales Share by Manufacturers
Table United States Active Pharmaceutical Ingredients Revenue by Manufacturers (2015 and 2016)
Table United States Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Active Pharmaceutical Ingredients Revenue Share by Manufacturers
Table 2016 United States Active Pharmaceutical Ingredients Revenue Share by Manufacturers
Table United States Market Active Pharmaceutical Ingredients Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Active Pharmaceutical Ingredients Average Price of Key Manufacturers in 2015
Figure Active Pharmaceutical Ingredients Market Share of Top 3 Manufacturers
Figure Active Pharmaceutical Ingredients Market Share of Top 5 Manufacturers
Table United States Active Pharmaceutical Ingredients Sales by States (2012-2017)
Table United States Active Pharmaceutical Ingredients Sales Share by States (2012-2017)
Figure United States Active Pharmaceutical Ingredients Sales Market Share by States in 2015
Table United States Active Pharmaceutical Ingredients Revenue and Market Share by States (2012-2017)
Table United States Active Pharmaceutical Ingredients Revenue Share by States (2012-2017)
Figure Revenue Market Share of Active Pharmaceutical Ingredients by States (2012-2017)
Table United States Active Pharmaceutical Ingredients Price by States (2012-2017)
Table United States Active Pharmaceutical Ingredients Sales by Type (2012-2017)
Table United States Active Pharmaceutical Ingredients Sales Share by Type (2012-2017)
Figure United States Active Pharmaceutical Ingredients Sales Market Share by Type in 2015
Table United States Active Pharmaceutical Ingredients Revenue and Market Share by Type (2012-2017)
Table United States Active Pharmaceutical Ingredients Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Active Pharmaceutical Ingredients by Type (2012-2017)
Table United States Active Pharmaceutical Ingredients Price by Type (2012-2017)
Figure United States Active Pharmaceutical Ingredients Sales Growth Rate by Type (2012-2017)
Table United States Active Pharmaceutical Ingredients Sales by Application (2012-2017)
Table United States Active Pharmaceutical Ingredients Sales Market Share by Application (2012-2017)
Figure United States Active Pharmaceutical Ingredients Sales Market Share by Application in 2015
Table United States Active Pharmaceutical Ingredients Sales Growth Rate by Application (2012-2017)
Figure United States Active Pharmaceutical Ingredients Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table Novartis International Basic Information List
Table Novartis International Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis International Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table Teva Pharmaceutical Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly and Company Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table Merck & Co Basic Information List
Table Merck & Co Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck & Co Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
Table AbbVie Active Pharmaceutical Ingredients Sales Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Bayer Basic Information List
Table Sun Pharmaceutical Industries Basic Information List
Table DSM Basic Information List
Table Hisun Pharmacy Basic Information List
Table Huahai Pharmaceutical Basic Information List
Table North China Pharmaceutical Group Basic Information List
Table Shandong Lukang Pharmaceutical Basic Information List
Table Haerbin Pharmaceutical Group Basic Information List
Table Shandong Xinhua Pharmaceutical Basic Information List
Table Jiangsu Hengrui Medicine Basic Information List
Table Lonza Group Basic Information List
Table Aurobindo Pharma Basic Information List
Table Lupin Basic Information List
Table Biocon Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Active Pharmaceutical Ingredients
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredients
Figure Active Pharmaceutical Ingredients Industrial Chain Analysis
Table Raw Materials Sources of Active Pharmaceutical Ingredients Major Manufacturers in 2015
Table Major Buyers of Active Pharmaceutical Ingredients
Table Distributors/Traders List
Figure United States Active Pharmaceutical Ingredients Production and Growth Rate Forecast (2017-2022)
Figure United States Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2017-2022)
Table United States Active Pharmaceutical Ingredients Production Forecast by Type (2017-2022)
Table United States Active Pharmaceutical Ingredients Consumption Forecast by Application (2017-2022)
Table United States Active Pharmaceutical Ingredients Sales Forecast by States (2017-2022)
Table United States Active Pharmaceutical Ingredients Sales Share Forecast by States (2017-2022)